Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Abbreviations

CI: confidence interval

EAC: early adenocarcinoma

EMR: endoscopic mucosal resection

ENT: ear, nose, and throat

ESGE: European Society of Gastrointestinal Endoscopy

FAP: familial adenomatous polyposis

GAVE: gastric antral vascular ectasia

HGD: high grade dysplasia

LGD: low grade dysplasia

MAPS: Management of precancerous conditions and lesions in the stomach

OLGA: Operative Link for Gastritis Assessment

OLGIM: Operative Link on Gastric Intestinal Metaplasia

OR: odds ratio

PEG: percutaneous endoscopic gastrostomy

PICO: population/patient; intervention/indicator; comparator/control; outcome

PPI: proton pump inhibitor

QIC: Quality improvement committee

SCC: squamous cell cancer

UEG: United European Gastroenterology

UGI: upper gastrointestinal tract

• References

• 1 Rutter MD, Senore C, Bisschops R et al. The European Society of Gastrointestinal Endoscopy Quality Improvement Initiative: developing performance measures. Endoscopy 2016; 48: 81-89
• 2 Kaminski MF, Regula J, Kraszewska E et al. Quality indicators for colonoscopy and the risk of interval cancer. NEJM 2010; 362: 1795-1803
• 3 Barclay RL, Vicari JJ, Doughty AS et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. NEJM 2006; 355: 2533-2541
• 4 Bennett C, Moayyedi P, Corley DA et al. BOB CAT: A large-scale review and Delphi consensus for management of Barrett’s esophagus with no dysplasia, indefinite for, or low-grade dysplasia. Am J Gastroenterol 2015; 110: 662-682 ; quiz 683
• 5 Bennett C, Vakil N, Bergman J et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012; 143: 336-346
• 6 Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
• 7 Koeppe A, Lubini M, Bonadeo N et al. Comfort, safety and quality of upper gastrointestinal endoscopy after 2 hours fasting: a randomized controlled trial. BMC Gastroenterol 2013; 13: 158
• 8 De Silva AP, Amarasiri L, Liyanage MN et al. One-hour fast for water and six-hour fast for solids prior to endoscopy provides good endoscopic vision and results in minimum patient discomfort. J Gastroenterol Hepatol 2009; 24: 1095-1097
• 9 Teh JL, Tan JR, Lau LJF et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2015; 13: 480-487.e2
• 10 Gupta N, Gaddam S, Wani SB et al. Longer inspection time is associated with increased detection of high-grade dysplasia and esophageal adenocarcinoma in Barrett’s esophagus. Gastrointest Endosc 2012; 76: 531-538
• 11 Park CH, Kim B, Chung H et al. Endoscopic quality indicators for esophagogastroduodenoscopy in gastric cancer screening. Dig Dis Sci 2015; 60: 38-46
• 12 Rey JF, Lambert R. ESGE recommendations for quality control in gastrointestinal endoscopy: guidelines for image documentation in upper and lower GI endoscopy. Endoscopy 2001; 33: 901-903
• 13 Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol Q Publ Hell Soc Gastroenterol 2013; 26: 11-22
• 14 Bretthauer M, Aabakken L, Dekker E et al. Requirements and standards facilitating quality improvement for reporting systems in gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2016; 48: 291-294
• 15 Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92
• 16 Lundell LR, Dent J, Bennett JR et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172-180
• 17 Armstrong D. Review article: towards consistency in the endoscopic diagnosis of Barrett’s oesophagus and columnar metaplasia. Aliment Pharmacol Ther 2004; 20: 40-47 ; discussion 61–62
• 18 Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-1399
• 19 Barclay RL, Vicari JJ, Greenlaw RL. Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol 2008; 6: 1091-1098
• 20 Dinis-Ribeiro M, Areia M, de Vries AC et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa. Endoscopy 2012; 44: 74-94
• 21 Areia M, Dinis-Ribeiro M, Rocha Gonçalves F. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions. Helicobacter 2014; 19: 425-436
• 22 Lambert R, Lightdale CJ. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon – November 30 to December 1, 2002. Gastrointest Endosc 2003; 58: S3-S4
• 23 Axon A, Diebold MD, Fujino M et al. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005; 37: 570-578
• 24 van Doorn SC, Hazewinkel Y, East JE et al. Polyp morphology: an interobserver evaluation for the Paris classification among international experts. Am J Gastroenterol 2015; 110: 180-187
• 25 Armstrong D, Bennett JR, Blum AL et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92
• 26 Pandolfino JE, Vakil NB, Kahrilas PJ. Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists. Gastrointest Endosc 2002; 56: 639-643
• 27 Vahabzadeh B, Seetharam AB, Cook MB et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc 2012; 75: 236-241
• 28 Alvarez Herrero L, Curvers WL, van Vilsteren FGI et al. Validation of the Prague C&M classification of Barrett’s esophagus in clinical practice. Endoscopy 2013; 45: 876-882
• 29 Forrest JA, Finlayson ND, Shearman DJ. Endoscopy in gastrointestinal bleeding. Lancet 1974; 2: 394-397
• 30 De Groot NL, Van Oijen MGH, Kessels K et al. Reassessment of the predictive value of the Forrest classification for peptic ulcer rebleeding and mortality: Can classification be simplified?. Endoscopy 2014; 46: 46-52
• 31 Gralnek I, Dumonceau J-M, Kuipers E et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: a1-a46
• 32 Cheng H-T, Cheng C-L, Lin C-H et al. Caustic ingestion in adults: the role of endoscopic classification in predicting outcome. BMC Gastroenterol 2008; 8: 31
• 33 LaBrecque D, Khan AG, Sarin SK et al. Esophageal Varices. World Gastroenterology Organisation Global Guidelines 2014. Available from: http://www.worldgastroenterology.org/UserFiles/file/guidelines/esophageal-varices-english-2014.pdf. Accessed 2016 July 4
• 34 de Franchis R, Baveno V. Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768
• 35 Spigelman AD, Williams CB, Talbot IC et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989; 2: 783-785
• 36 Syngal S, Brand RE, Church JM et al. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015; 110: 223-262 ; quiz 263
• 37 Bennett C, Moayyedi P, Corley DA et al. BOB CAT: A large-scale review and Delphi consensus for management of Barrett’s esophagus with no dysplasia, indefinite for, or low-grade dysplasia. Am J Gastroenterol 2015; 110: 662-682 ; quiz 683
• 38 Fitzgerald RC, di Pietro M, Ragunath K et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut 2014; 63: 7-42
• 39 Tincani AJ, Brandalise N, Altemani A et al. Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% lugol dye solution in patients with head and neck cancer. Head Neck 2000; 22: 170-174
• 40 Hashimoto CL, Iriya K, Baba ER et al. Lugol’s dye spray chromoendoscopy establishes early diagnosis of esophageal cancer in patients with primary head and neck cancer. Am J Gastroenterol 2005; 100: 275-282
• 41 Dubuc J, Legoux J-L, Winnock M et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers. Endoscopy 2006; 38: 690-695
• 42 Boller D, Spieler P, Schoenegg R et al. Lugol chromoendoscopy combined with brush cytology in patients at risk for esophageal squamous cell carcinoma. Surg Endosc 2009; 23: 2748-2754
• 43 Carvalho R, Areia M, Brito D et al. Diagnostic accuracy of lugol chromoendoscopy in the oesophagus in patients with head and neck cancer. Rev Esp Enferm Dig 2013; 105: 79-83
• 44 Komínek P, Vítek P, Urban O et al. Chromoendoscopy to detect early synchronous second primary esophageal carcinoma in patients with squamous cell carcinomas of the head and neck?. Gastroenterol Res Pract 2013; 2013: 236264
• 45 Ina H, Shibuya H, Ohashi I et al. The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer. Screening results using Lugol dye endoscopy. Cancer 1994; 73: 2038-2041
• 46 Shiozaki H, Tahara H, Kobayashi K et al. Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer 1990; 66: 2068-2071
• 47 Reid BJ, Blount PL, Feng Z et al. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am J Gastroenterol 2000; 95: 3089-3096
• 48 Spechler SJ, Sharma P, Souza RF et al. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 2011; 140: 1084-1091
• 49 Abela JE, Going JJ, Mackenzie JF et al. Systematic four-quadrant biopsy detects Barrett’s dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol 2008; 103: 850-855
• 50 Peters FP, Curvers WL, Rosmolen WD et al. Surveillance history of endoscopically treated patients with early Barrett’s neoplasia: Nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus 2008; 21: 475-479
• 51 Kariv R, Plesec TP, Goldblum JR et al. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol. Clin Gastroenterol Hepatol 2009; 7: 653-658
• 52 Rugge M, Meggio A, Pennelli G et al. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007; 56: 631-636
• 53 Capelle LG, de Vries AC, Haringsma J et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010; 71: 1150-1158
• 54 de Vries AC, Haringsma J, de Vries RA et al. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter 2010; 15: 259-264
• 55 Guarner J, Herrera-Goepfert R, Mohar A et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum Pathol 2003; 34: 28-31
• 56 Eriksson NK, Färkkilä MA, Voutilainen ME et al. The clinical value of taking routine biopsies from the incisura angularis during gastroscopy. Endoscopy 2005; 37: 532-536
• 57 El-Zimaity HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 1999; 30: 72-77
• 58 Isajevs S, Liepniece-Karele I, Janciauskas D et al. The effect of incisura angularis biopsy sampling on the assessment of gastritis stage. Eur J Gastroenterol Hepatol 2014; 26: 510-513
• 59 Stolte M, Müller H, Talley NJ et al. In patients with Helicobacter pylori gastritis and functional dyspepsia, a biopsy from the incisura angularis provides useful diagnostic information. Pathol Res Pract 2006; 202: 405-413
• 60 Cabrera Chamorro C, Méndez Manchola C, Molina Ramírez I et al. [Endoscopic balloon dilatation of esophageal strictures in children]. Cir Pediatr 2013; 26: 106-111
• 61 Caro L, Sánchez C, Rodríguez P et al. Endoscopic balloon dilation of anastomotic strictures occurring after laparoscopic gastric bypass for morbid obesity. Dig Dis 2008; 26: 314-317
• 62 Contini S, Garatti M, Swarray-Deen A et al. Corrosive oesophageal strictures in children: outcomes after timely or delayed dilatation. Dig Liver Dis 2009; 41: 263-268
• 63 Contini S, Tesfaye M, Picone P et al. Corrosive esophageal injuries in children. A shortlived experience in Sierra Leone. Int J Pediatr Otorhinolaryngol 2007; 71: 1597-1604
• 64 Dellon ES, Gibbs WB, Rubinas TC et al. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc 2010; 71: 706-712
• 65 Fry LC, Mönkemüller K, Neumann H et al. Incidence, clinical management and outcomes of esophageal perforations after endoscopic dilatation. Zeitschrift für Gastroenterol 2007; 45: 1180-1184
• 66 Hagel AF, Naegel A, Dauth W et al. Perforation during esophageal dilatation: a 10-year experience. J Gastrointestin Liver Dis 2013; 22: 385-389
• 67 Jayakrishnan VK, Wilkinson AG. Treatment of oesophageal strictures in children: a comparison of fluoroscopically guided balloon dilatation with surgical bouginage. Pediatr Radiol 2001; 31: 98-101
• 68 Ko H-K, Shin JH, Song H-Y et al. Balloon dilation of anastomotic strictures secondary to surgical repair of esophageal atresia in a pediatric population: long-term results. J Vasc Interv Radiol 2006; 17: 1327-1333
• 69 Laín A, Cerdá J, Cañizo A et al. [Analysis of esophageal strictures secondary to surgical correction of esophageal atresia]. Cir Pediatr 2007; 20: 203-208
• 70 Lakhdar-Idrissi M, Khabbache K, Hida M. Esophageal endoscopic dilations. J Pediatr Gastroenterol Nutr 2012; 54: 744-747
• 71 Lan LCL, Wong KKY, Lin SCL et al. Endoscopic balloon dilatation of esophageal strictures in infants and children: 17 years’ experience and a literature review. J Pediatr Surg 2003; 38: 1712-1715
• 72 Lang T, Hümmer HP, Behrens R. Balloon dilation is preferable to bougienage in children with esophageal atresia. Endoscopy 2001; 33: 329-335
• 73 Lian JJ, Ma LL, Hu JW et al. Endoscopic balloon dilatation for benign esophageal stricture after endoscopic submucosal dissection for early esophageal neoplasms. J Dig Dis 2014; 15: 224-229
• 74 Na HK, Choi KD, Ahn JY et al. Outcomes of balloon dilation for the treatment of strictures after endoscopic submucosal dissection compared with peptic strictures. Surg Endosc 2013; 27: 3237-3246
• 75 Poddar U, Thapa BR. Benign esophageal strictures in infants and children: results of Savary-Gilliard bougie dilation in 107 Indian children. Gastrointest Endosc 2001; 54: 480-484
• 76 Qureshi S, Ghazanfar S, Leghari A et al. Benign esophageal strictures: behaviour, pattern and response to dilatation. J Pak Med Assoc 2010; 60: 656-660
• 77 Rana SS, Bhasin DK, Chandail VS et al. Endoscopic balloon dilatation without fluoroscopy for treating gastric outlet obstruction because of benign etiologies. Surg Endosc 2011; 25: 1579-1584
• 78 Raymondi R, Pereira-Lima JC, Valves A et al. Endoscopic dilation of benign esophageal strictures without fluoroscopy: experience of 2750 procedures. Hepatogastroenterology 2008; 55: 1342-1348
• 79 Romeo E, Foschia F, de Angelis P et al. Endoscopic management of congenital esophageal stenosis. J Pediatr Surg 2011; 46: 838-841
• 80 Said M, Mekki M, Golli M et al. Balloon dilatation of anastomotic strictures secondary to surgical repair of oesophageal atresia. Br J Radiol 2003; 76: 26-31
• 81 Shehata SMK, Enaba ME. Endoscopic dilatation for benign oesophageal strictures in infants and toddlers: experience of an expectant protocol from North African tertiary centre. Afr J Paediatr Surg 2012; 9: 187-192
• 82 Thyoka M, Barnacle A, Chippington S et al. Fluoroscopic balloon dilation of esophageal atresia anastomotic strictures in children and young adults: single-center study of 103 consecutive patients from 1999 to 2011. Radiology 2014; 271: 596-601
• 83 Ukleja A, Shiroky J, Agarwal A et al. Esophageal dilations in eosinophilic esophagitis: a single center experience. World J Gastroenterol 2014; 20: 9549-9555
• 84 Uygun I, Arslan MS, Aydogdu B et al. Fluoroscopic balloon dilatation for caustic esophageal stricture in children: an 8-year experience. J Pediatr Surg 2013; 48: 2230-2234
• 85 Weintraub JL, Eubig J. Balloon catheter dilatation of benign esophageal strictures in children. J Vasc Interv Radiol 2006; 17: 831-835
• 86 Yeming W, Somme S, Chenren S et al. Balloon catheter dilatation in children with congenital and acquired esophageal anomalies. J Pediatr Surg 2002; 37: 398-402
• 87 Yoda Y, Yano T, Kaneko K et al. Endoscopic balloon dilatation for benign fibrotic strictures after curative nonsurgical treatment for esophageal cancer. Surg Endosc 2012; 26: 2877-2883
• 88 Albéniz-Arbizu E, Pueyo-Royo A, Eguaras-Ros J et al. Endoscopic mucosal resection for proximal superficial lesions: efficacy and safety study in 59 consecutive resections. Rev Esp Enferm Dig 2012; 104: 458-467
• 89 Alexander S, Bourke MJ, Williams SJ et al. EMR of large, sessile, sporadic nonampullary duodenal adenomas: technical aspects and long-term outcome (with videos). Gastrointest Endosc 2009; 69: 66-73
• 90 Basford PJ, George R, Nixon E et al. Endoscopic resection of sporadic duodenal adenomas: comparison of endoscopic mucosal resection (EMR) with hybrid endoscopic submucosal dissection (ESD) techniques and the risks of late delayed bleeding. Surg Endosc 2014; 28: 1594-1600
• 91 Binmoeller KF, Shah JN, Bhat YM et al. “Underwater” EMR of sporadic laterally spreading nonampullary duodenal adenomas (with video). Gastrointest Endosc 2013; 78: 496-502
• 92 Conio M, De Ceglie A, Filiberti R et al. Cap-assisted EMR of large, sporadic, nonampullary duodenal polyps. Gastrointest Endosc 2012; 76: 1160-1169
• 93 Conio M, Fisher DA, Blanchi S et al. One-step circumferential endoscopic mucosal cap resection of Barrett’s esophagus with early neoplasia. Clin Res Hepatol Gastroenterol 2014; 38: 81-91
• 94 Fanning SB, Bourke MJ, Williams SJ et al. Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats. Gastrointest Endosc 2012; 75: 805-812
• 95 Huntington JT, Walker JP, Meara MP et al. Endoscopic mucosal resection for staging and treatment of early esophageal carcinoma: a single institution experience. Surg Endosc 2015; 29: 2121-2125
• 96 Inoue T, Uedo N, Yamashina T et al. Delayed perforation: a hazardous complication of endoscopic resection for non-ampullary duodenal neoplasm. Dig Endosc 2014; 26: 220-227
• 97 Kakushima N, Ono H, Takao T et al. Method and timing of resection of superficial non-ampullary duodenal epithelial tumors. Dig Endosc 2014; 26 (Suppl. 02) 35-40
• 98 Kim GH, Kim JI, Jeon SW et al. Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study. J Gastroenterol Hepatol 2014; 29: 318-324
• 99 Kim H-K, Chung WC, Lee B-I et al. Efficacy and long-term outcome of endoscopic treatment of sporadic nonampullary duodenal adenoma. Gut Liver 2010; 4: 373-377
• 100 Konda VJA, Gonzalez Haba Ruiz M, Koons A et al. Complete endoscopic mucosal resection is effective and durable treatment for Barrett’s-associated neoplasia. Clin Gastroenterol Hepatol 2014; 12: 2002-2010.e1-e2
• 101 Lee KJ, Kim GH, Park DY et al. Endoscopic resection of gastrointestinal lipomas: a single-center experience. Surg Endosc 2014; 28: 185-192
• 102 Li N, Pasricha S, Bulsiewicz WJ et al. Effects of preceding endoscopic mucosal resection on the efficacy and safety of radiofrequency ablation for treatment of Barrett’s esophagus: results from the United States Radiofrequency Ablation Registry. Dis Esophagus 2015; Epub ahead of print
• 103 Makazu M, Kato K, Takisawa H et al. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer. Dis Esophagus 2014; 27: 42-49
• 104 Matsumoto S, Yoshida Y. Selection of appropriate endoscopic therapies for duodenal tumors: an open-label study, single-center experience. World J Gastroenterol 2014; 20: 8624-8630
• 105 Min B-H, Kim ER, Lee JH et al. Management strategy for small duodenal carcinoid tumors: does conservative management with close follow-up represent an alternative to endoscopic treatment?. Digestion 2013; 87: 247-253
• 106 Min YW, Min B-H, Kim ER et al. Efficacy and safety of endoscopic treatment for nonampullary sporadic duodenal adenomas. Dig Dis Sci 2013; 58: 2926-2932
• 107 Navaneethan U, Lourdusamy D, Mehta D et al. Endoscopic resection of large sporadic non-ampullary duodenal polyps: efficacy and long-term recurrence. Surg Endosc 2014; 28: 2616-2622
• 108 Nonaka S, Oda I, Tada K et al. Clinical outcome of endoscopic resection for nonampullary duodenal tumors. Endoscopy 2015; 47: 129-135
• 109 Oka S, Tanaka S, Higashiyama M et al. Clinical validity of the expanded criteria for endoscopic resection of undifferentiated-type early gastric cancer based on long-term outcomes. Surg Endosc 2014; 28: 639-647
• 110 Oka S, Tanaka S, Nagata S et al. Clinicopathologic features and endoscopic resection of early primary nonampullary duodenal carcinoma. J Clin Gastroenterol 2003; 37: 381-386
• 111 Park SM, Ham JH, Kim B-W et al. Feasibility of endoscopic resection for sessile nonampullary duodenal tumors: a multicenter retrospective study. Gastroenterol Res Pract 2015; 2015: 692492
• 112 Pimentel-Nunes P, Mourão F, Veloso N et al. Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal. Endoscopy 2014; 46: 933-940
• 113 Qumseya B, David W, Woodward TA et al. Safety of esophageal EMR in elderly patients. Gastrointest Endosc 2014; 80: 586-591
• 114 Seo JY, Hong SJ, Han JP et al. Usefulness and safety of endoscopic treatment for nonampullary duodenal adenoma and adenocarcinoma. J Gastroenterol Hepatol 2014; 29: 1692-1698
• 115 Sohn JW, Jeon SW, Cho CM et al. Endoscopic resection of duodenal neoplasms: a single-center study. Surg Endosc 2010; 24: 3195-3200
• 116 Uygun A, Kadayifci A, Polat Z et al. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors. J Surg Oncol 2014; 109: 71-74
• 117 Yamamoto Y, Yoshizawa N, Tomida H et al. Therapeutic outcomes of endoscopic resection for superficial non-ampullary duodenal tumor. Dig Endosc 2014; 26 (Suppl. 02) 50-56
• 118 Zhong Y-S, Shi Q, Wu H-F et al. Endoscopic resection for the treatment of duodenal Brunner’s adenomas. J Laparoendosc Adv Surg Tech A 2012; 22: 904-909
• 119 van Zuuren FJ, Grypdonck M, Crevits E et al. The effect of an information brochure on patients undergoing gastrointestinal endoscopy: a randomized controlled study. Patient Educ Couns 2006; 64: 173-182
• 120 Ajumobi A, Bahjri K, Jackson C et al. Surveillance in Barrett’s esophagus: An audit of practice. Dig Dis Sci 2010; 55: 1615-1621
• 121 Bansal A, Mcgregor DH, Anand O et al. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett’s esophagus. Dis Esophagus 2014; 27: 751-756
• 122 Basu KK, Pick B, de Caestecker JS. Audit of a Barrett’s epithelium surveillance database. Eur J Gastroenterol Hepatol 2004; 16: 171-175
• 123 Bertani H, Frazzoni M, Dabizzi E et al. Improved detection of incident dysplasia by probe-based confocal laser endomicroscopy in a Barrett’s esophagus surveillance program. Dig Dis Sci 2013; 58: 188-193
• 124 Canto MIF, Setrakian S, Willis J et al. Methylene blue–directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest Endosc 2000; 51: 560-568
• 125 Conio M, Blanchi S, Lapertosa G et al. Long-term endoscopic surveillance of patients with Barrett’s esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study. Am J Gastroenterol 2003; 98: 1931-1939
• 126 Egger K, Werner M, Meining A et al. Biopsy surveillance is still necessary in patients with Barrett’s oesophagus despite new endoscopic imaging techniques. Gut 2003; 52: 18-23
• 127 Gladman L, Chapman W, Iqbal TH et al. Barrett’s oesophagus: an audit of surveillance over a 17-year period. Eur J Gastroenterol Hepatol 2006; 18: 271-276
• 128 Gopal DV, Lieberman DA, Magaret N et al. Risk factors for dysplasia in patients with Barrett’s esophagus (BE): Results from a multicenter consortium. Dig Dis Sci 2003; 48: 1537-1541
• 129 de Jonge PJ, van Blankenstein M, Looman CW et al. Risk of malignant progression in patients with Barrett’s oesophagus: a Dutch nationwide cohort study. Gut 2010; 59: 1030-1036
• 130 Sharma P, Hawes RH, Bansal A et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett’s oesophagus: a prospective, international, randomised controlled trial. Gut 2013; 62: 15-21
• 131 Hillman LC, Chiragakis L, Clarke AC et al. Barrett’s esophagus: Macroscopic markers and the prediction of dysplasia and adenocarcinoma. J Gastroenterol Hepatol 2003; 18: 526-533
• 132 Hurschler D, Borovicka J, Neuweiler J et al. Increased detection rates for Barrett’s oesophagus without rise in incidence of oesophageal adenocarcinoma. Swiss Med Wkly 2003; 133: 507-514
• 133 Komanduri S, Swanson G, Keefer L et al. Use of a new jumbo forceps improves tissue acquisition of Barrett’s esophagus surveillance biopsies. Gastrointest Endosc 2009; 70: 1072-1078.e1
• 134 Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett’s oesophagus: Observational study. BMJ 2000; 321: 1252-1255
• 135 Murphy SJ, Dickey W, Hughes D et al. Surveillance for Barrett’s oesophagus: results from a programme in Northern Ireland. Eur J Gastroenterol Hepatol 2005; 17: 1029-1035
• 136 Oberg S, Wenner J, Johansson J et al. Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005; 242: 49-54
• 137 Olithselvan A, Gorard DA, McIntyre AS. A surveillance programme for Barrett’s oesophagus in a UK general hospital. Eur J Gastroenterol Hepatol 2007; 19: 305-309
• 138 Pohl J, Pech O, May A et al. Incidence of macroscopically occult neoplasias in Barrett’s esophagus: are random biopsies dispensable in the era of advanced endoscopic imaging?. Am J Gastroenterol 2010; 105: 2350-2356
• 139 Ramus JR, Gatenby PA, Caygill CPJ et al. Surveillance of Barrett’s columnar-lined oesophagus in the UK: endoscopic intervals and frequency of detection of dysplasia. Eur J Gastroenterol Hepatol 2009; 21: 636-641
• 140 Rudolph RE, Vaughan TL, Storer BE et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 2000; 132: 612-620
• 141 Rugge M, Zaninotto G, Parente P et al. Barrettʼs esophagus and Adenocarcinoma Risk. Ann Surg 2012; 256: 788-795
• 142 Sharma P, Weston AP, Topalovski M et al. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett’s oesophagus. Gut 2003; 52: 24-27
• 143 Sharma P, Bansal A, Mathur S et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett’s esophagus. Gastrointest Endosc 2006; 64: 167-175
• 144 Terry NG, Zhu Y, Rinehart MT et al. Detection of dysplasia in barrett’s esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology 2011; 140: 42-50
• 145 Wani S, Falk G, Hall M et al. Patients with nondysplastic Barrett’s esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2011; 9: 220-227.e1
• 146 Wong T, Tian J, Nagar AB. Barrett’s surveillance identifies patients with early esophageal adenocarcinoma. Am J Med 2010; 123: 462-427